{"id":"W2092096790","doi":"10.1038/jid.2013.378","title":"Is a Single BRAF Wild-Type Test Sufficient to Exclude Melanoma Patients from Vemurafenib Therapy?","year":2013,"lang":"en","type":"letter","venue":"Journal of Investigative Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Institut National Du Cancer","keywords":"Vemurafenib; Medicine; Melanoma; Dermatology; Test (biology); Oncology; Internal medicine; Cancer research; Metastatic melanoma; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001029995,0.0005660412,0.0009032362,0.0002727476,0.00009800846,0.00006816026,0.0007706356,0.001144539,0.0001628426],"category_scores_gemma":[0.0006403962,0.0004668828,0.000312982,0.0001977988,0.0003510143,0.00001541095,0.0002109252,0.001042933,0.0001796909],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006687654,"about_ca_system_score_gemma":0.0003768653,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004768647,"about_ca_topic_score_gemma":0.000009855515,"domain_scores_codex":[0.9970806,0.0003424429,0.001002428,0.0005581154,0.0004533019,0.000563103],"domain_scores_gemma":[0.9966918,0.0001762004,0.001187559,0.000554349,0.001065893,0.0003242068],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005028717,0.0001633893,0.003906852,0.000020679,0.0002480255,0.0002397747,0.0004222852,0.000001753774,0.2614216,0.000002192765,0.7333646,0.0001585397],"study_design_scores_gemma":[0.0008456411,0.001945365,0.002676477,0.00008057698,0.00005023813,0.0002608203,0.00003814548,0.000002902133,0.4531212,0.0001943733,0.5404147,0.0003695913],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.8943635,0.001045066,0.00006384149,0.102449,0.001112617,0.0003833327,0.0002121939,0.000009410555,0.0003610807],"genre_scores_gemma":[0.375161,0.0001385257,0.001898909,0.6182281,0.002935786,0.00002523391,0.0008481797,0.0001241259,0.000640145],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.5192024,"threshold_uncertainty_score":0.9997783,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03078801824767424,"score_gpt":0.2380656927843419,"score_spread":0.2072776745366677,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}